1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]-

Request For Quotation

1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]- manufacturers

  • ATR-IN-5
  • ATR-IN-5 pictures
  • $1980.00
  • 2026-04-21
  • CAS:2601571-19-9
  • Purity:
  • Supply Ability: 10g
1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]- Basic information
Product Name:1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]-
Synonyms:1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]-;ATR-IN-5
CAS:2601571-19-9
MF:C27H32F3N9O
MW:555.6
EINECS:
Product Categories:
Mol File:2601571-19-9.mol
1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]- Structure
1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]- Chemical Properties
Boiling point 754.6±70.0 °C(Predicted)
density 1.48±0.1 g/cm3(Predicted)
pka9.71±0.10(Predicted)
Safety Information
MSDS Information
1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]- Usage And Synthesis
UsesATR-IN-5 is a potent inhibitor of ATR. ATR is a class of protein kinases involved in genome stability and DNA damage repair, and is a member of the PIKK family. ATR-IN-5 has the potential for the research of ATR kinase-mediated diseases such as proliferative diseases and cancer (extracted from patent CN112047938A, compound D24)[1].
References[1] Zhao, Yanping, et al. 2,4,6-Trisubstituted pyrimidine compounds as atr kinase inhibitors. Patent CN112047938A.
1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]- Preparation Products And Raw materials
Tag:1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]-(2601571-19-9) Related Product Information
1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-6-[3-methyl-1-(4-piperidinyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]- 2,2-Diphenyl-N-(2,2,2-trichloro-1-[3-(4-fluoro-3-nitrophenyl)thioureido]ethyl)acetamide 7H-Pyrrolo[2,3-d]pyrimidine, 4-[(3R)-3-methyl-4-morpholinyl]-7-(methylsulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)- AZD-1390 camonsertib AZD-0156